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Bradykinin stimulates c-fos expression, AP-1-DNA binding
activity and proliferation of rat glomerular mesangial cells
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Bradykinin stimulates c-los expression, AP-1-DNA binding activity and
proliferation of rat glomerular mesangial cells. An important role for
bradykinin (BK) in nephrogenesis has been suggested based on impair-
ment of renal growth in developing rats treated with a kinin antagonist.
However, direct effects of BK on renal cell mitogenesis have not been
reported. In the present study, we examined the mitogenic effects of BK
on cultured rat mesangial cells. Transcripts encoding BK-B2 receptors
were detected in quiescent and proliferating mesangial cells by reverse
transcription-coupled polymerase chain reaction. In quiescent mesangial
cell cultures (0.5% FCS for 48 hr), BK (10° to iO M) caused a
significant increase in DNA synthesis (3H-thymidine incorporation into
DNA) and cell number. BK-induced DNA synthesis was preceded by
activation of c-fos gene expression and both of these effects were inhibited
by Hoe-140, a specific BK-B2 antagonist. Electrophoretic gel mobility shift
assays revealed enhanced binding of AP-l complexes to a consensus AP-1
DNA sequence in BK-stimulated cells. Gel supershift assays confirmed
that the AP-1 complexes contained the fos protein. These data document
a direct mitogenic effect of BK, acting on B2 receptors, on mesangial cells.
Mesangial cell proliferation is essential for normal glomerulo-
genesis. In vitro, mesangial cells proliferate in response to a
number of peptide growth factors such as platelet-derived growth
factor, fibroblast growth factor, transforming growth factor-a, and
epidermal growth factor [1]. In contrast, transforming growth
factor (TGF)-f3 appears to act as a negative regulator of the
mesangial cell cycle [1, 2]. Additionally, there is increasing
evidence that G-protein-coupled receptors play a role in the
regulation of glomerular growth and mesangial proliferation. For
example, endothelin [3] and thrombin [4] are potent mitogens in
mesangial cells. In addition, angiotensin II, acting via type 1
(AT1) receptors, stimulates proliferation of cultured human fetal
mesangial cells [5], and AT1 receptor antagonists retard glomer-
ular growth in neonatal rats [6].
Recent studies from our laboratory have suggested that the
G-protein-coupled bradykinin (BK)-B2 receptor may also be
important in renal growth and differentiation. We found that
BK-B2 receptors are up-regulated during the latter part of
nephrogenesis, and that blockade of BK-B2 receptors in salt-
loaded pregnant rats results in a significant reduction in the
number of fetal glomeruli [7]. In addition, neonatal blockade of
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the BK-B2 receptors results in renal growth retardation and
decreased kidney DNA synthesis [8]. Taken together, these data
suggested that BK has the capacity to stimulate renal cell growth,
and led us to hypothesize that BK is coupled to proliferative
growth. To test this hypothesis, the effect of BK on rat mesangial
cell growth was studied in vitro, isolated from the effects of BK on
renal and systemic hemodynamics. The effects of BK on DNA
synthesis, cell number, expression of immediate early genes and
the DNA binding activity of the transcription factor AP-1 were
evaluated. In addition, using a selective receptor antagonist, we
examined whether the observed growth responses were mediated
through activation of the B2-receptor type.
Methods
Materials
Bradykinin, phenylmethylsulfonyl fuoride (PMSF), leupeptin,
pepstatin A, aprotinin, bestatin, nonidet P40, and spermidine
were all obtained from Sigma Chemical Co. (St. Louis, MO,
USA). RPMI 1640 and fetal calf serum (FCS) were obtained from
Gibco/BRL Life Technologies (Grand Island, NY, USA). 3H-
thymidine was obtained from ICN Pharmaceuticals (Costa Mesa,
CA, USA), and polydldC from Pharmacia Biotech Inc. (Piscat-
away, NJ, USA). All other reagents were molecular biology grade.
Mesangial cell culture
Mesangial cells were obtained from intact glomeruli of male
Sprague-Dawley rats (200 to 250 g) and were characterized as
described previously by Wong, Cortez and Baricos [9]. Briefly,
cultured cells were identified as mesangial cells by the following
criteria. (1) After three to four passages, all cells were stellate or
spindle-shaped with irregular cytoplasmic projections. The cells
did not exhibit contact inhibition and became multilayered if
allowed to grow beyond confluence without passage. (2) Immu-
nofluorescent staining was positive for the mesangial cell markers
Thy-1.1, fibronectin, and actin; and negative for the endothelial
cell marker factor VIII. (3) Fibroblast contamination was assessed
and found to be negative by the ability of the cells to grow in
medium containing D-valine in place of L-valine. Mesangial cells
were maintained in RPM! 1640 medium supplemented with 10%
fetal calf serum (FCS), 100 U/ml penicillin, 100 jsg/ml streptomy-
cm, 2.0 mrvi L-glutamine at 37°C in 5% CO2 in humidified air. For
all experiments, cells at 70 to 80% confluence were made quies-
cent by incubation for 48 hours in fresh RPMI 1640 medium
containing 0.5% FCS. Cells were used at passage numbers 8 to 13.
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DNA synthesis
Quiescent mesangial cells in 24-well plates (10 cells/well) were
stimulated for 24 hours with BK in the presence or absence of the
selective BK-B2 receptor antagonist, Hoe 140 (D-Arg-Arg-Pro-
Hyp-Gly-Thi-Ser-D-Tic-Oic-Arg) [10]. The cells were labeled
with 1 jCi/ml [methyl-3H] thymidine for the last eight hours of
incubation. To stop the incubation, the medium was withdrawn
and the cells were washed twice with cold phosphate buffered
saline, trypsinized, and collected by centrifugation (150 x g for 5
mm). The cell pellet was suspended in cold 10% trichloroacetic
acid (TCA) and incubated for 30 minutes at 4°C. Cells were then
washed twice with 5% TCA and incubated for 30 minutes at 37°C
in 1 M NaOH to solubilize the DNA, and the radioactivity
incorporated into DNA was counted in a 13-scintillation counter.
Cell numbers were determined by trypan blue exclusion assay
using a hemocytometer. All experiments were performed in
triplicates or quadruplicates and were repeated three to four
times.
RNA blot analysis
Total cellular RNA from quiescent and BK-treated mesangial
cells (N = 3 separate experiments) was isolated by the guanidine
isothiocyanate protocol of Chomczynski and Sacchi [11]. An equal
amount of total RNA (10 or 20 tg) from quiescent, BK-treated,
and BKHoe-140-treated cells was size fractionated on 1%
(wt/vol) agarose gel in 25 m Mops buffer (pH 7.5) containing 1
mM EDTA and 2% (wt/vol) formaldehyde. RNA was transferred
to a positively charged GeneScreen Plus membrane (NEN Re-
search Products, Boston, MA, USA) by vacuum blotting. RNA
was cross-linked to the membrane using ultraviolet irradiation
(Stratalinker; Stratagene Inc., La Jolla, CA, USA). The cDNAs (a
PstI 1.0-kb fragment of v-fos oncogene [12]; an EcoRI 2.6-kb
fragment of mouse c-jun cDNA [13]; and a PsTI 1.2-kb fragment
of human glyceraldehyde 3-phosphate dehydrogenase [GAPDH]
cDNA [14] (all from ATCC) were labeled with [a-32P]-dCTP
using a random primers labeling kit according to the manufactur-
er's protocol (GIBCO BRL, Gaithersburg, MD, USA). The
labeled cDNA probes were separated from unincorporated nu-
cleotides by Sephadex G-50 Nick columns (Pharmacia), and
membranes were hybridized with iO cpm/ml probe for 20 hours
at 65°C using hybridization and washing conditions as previously
described [15]. The membranes were then autoradiographed with
intensifying screens (DuPont, Wilmington, DE, USA) at —70°C
for one to seven days. Blots were then stripped for 30 minutes at
95°C with 0.01 x SSC and 0.01% SDS and rehybridized with a
probe for GAPDH to correct for loading and transfer variations.
Autoradiographic signals were quantitated with a scanning den-
sitometer (Ultroscan; Pharmacia LKB, Uppsala, Sweden) and
mRNA levels were calculated relative to those of GAPDH.
Reverse transcription-polymerase chain reaction (RT-PCR) of BK-
B2 mRNA
BK-B2 receptor mRNA in quiescent (passage 11) or prolifer-
ating (passage 14) mesangial cells was detected by RT-PCR (N =
3). The RT mixture (12 d) contained 3 jig of total cellular RNA,
1 ng of random hexamers, 1 jd of 10 mrvi dNTP, 2 jil of lOx RT
buffer [200 mM Tris-HC1 (pH 8.4), 500 mM KC1, 15 mM MgCI2]
and 200 U of MLV reverse transcriptase Superscript II (BRL).
RT was performed using Perkin Elmer Gene Amp PCR System
2400 (Cetus Instruments, Norwalk, CT, USA) at 37°C for 50
minutes and the RT enzyme was inactivated by heating at 70°C for
10 minutes. The template mRNA was degraded by incubating the
samples with 2 units of E. coli RNase H at 37°C for 20 minutes.
cDNA was amplified from 25% of RT mixture by PCR using B2
receptor gene-specific primers (25 pmol of each), 1 unit of
thermostable DNA polymerase from Thermus aquaticus (Taq
polymerase), 5 pA of lox PCR buffer and 1 pA of 10 mM dNTP (30
cycles; 94°C, 1 mm; 58°C, 2 mm; 72°C, 3 mm). The upstream
primer corresponds to nucleotides 161 to 182 of rat B2 receptor
cDNA [5'-AGAACATCTTTGTCCTCAGCG-3'], and the dow-
stream primer is complementary to nucleotides 714 to 733 of rat
B2 receptor cDNA [5'-CGTCTGGACCTCCYFGAACT-3'] [16].
The predicted size of the PCR product is 572 bp. The specificity
of the PCR product was confirmed by restriction enzyme digestion
with NcoI which resulted in two fragments (268 and 304 bp) and
by Southern blot analysis [17].
Electrophoretic gel mobility shift assays
Mesangial cells were harvested following treatment with BK for
30 minutes or two hours in the presence and absence of the
B2-receptor antagonist Hoe-140. Whole-cell extracts were pre-
pared by sonication at 4°C in 1 ml of buffer [20 mivi HEPES (pH
7.8), 125 mi NaCl, 5 mi MgCI2, 12% glycerol, 0.2 mt EDTA,
BSA (1 mg/ml), 0.1% Nonidet P-40, 5 m dithiothreitol (DTT),
0.5 mM PMSF, leupeptin (0.5 jig/ml), pepstatin (0.7 jig/mI),
aprotinin (1 jig/ml), and bestatin (40 jig/mI)]. Extracts were then
centrifuged at 15,600 g for 10 minutes (at 4°C) and the superna-
tants collected. The AP-1 consensus oligonucleotide used in the
binding reaction is a double-stranded 21 nucleotide, 5'-CGCTT-
GATGACTCAGCCGGAA-3'. (Boldface indicates consensus
AP-1 binding site) (from Santa Cruz) with binding sites for AP-1
c-jun homodimer and jun/fos heterodimeric complexes. Oligonu-
cleotides were radiolabeled with y32P-ATP and T4 kinase. Bind-
ing assays were performed with 5 to 10 jig of protein extracts, 1.5
jig of poly[d(I-C)], 5 pA of buffer [50 mM HEPES (pH 7.8), 5 mM
spermidine, 15 mrvi MgCl2, 36% glycerol, BSA (3 mg/mI), 0.3%
Nonidet P-40, and 15 ms DIT], and 40,000 to 70,000 cpm of
32P-labeled oligonucleotide, with water added to a final volume of
25 jil. Reactions were incubated for 15 minutes on ice before
addition of 32P-labeled oligonucleotide, then for an additional 15
minutes at 22°C. For competition with unlabeled oligonucleotide,
a 100-fold molar excess of oligonucleotide relative to the radio-
labeled probe was added to the binding assay. Supershift experi-
ments were performed to determine the composition of the
complexes using c-fos antibodies (Santa Cruz). In these experi-
ments, 1 jig of antibody was added to the reaction 45 minutes
before addition of labeled probe and the mixture was kept at 4°C
overnight. Samples were electrophoresed on 4% nondenaturing
polyacrylamide gels, dried, and autoradiographed. All experi-
ments were repeated at least three times.
Statistical analysis
Differences among the treatment groups in the DNA synthesis
and cell number experiments were analyzed by analysis of vari-
ance. For the Northern blot analysis of immediate-early genes
mRNA, autoradiographic signals were scanned using laser densi-
tometry and the values normalized for GAPDH. Differences
between controls, BK-treated, and Hoe-treated groups were
analyzed by analysis of variance.
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Fig. 1. RT-PCR of BK-B2 receptor mRNA in cultured rat mesangial cells.
Three micrograms of total RNA, isolated from quiescent cells (0.5%
FCS X 48 hr) in passage 11 [P111 or proliferating cells (10% FCS X 48 hr)
in passage 14 [P141, were reverse-transcribed and the cDNAs subjected to
PCR amplification using B2-receptor-specific primers. The size of the
RT-PCR product is 572 bp. [Cj is an unrelated RNA supplied by the
manufacturer as a positive control for the RT step.
Results
Cultured rat mesangial cells express BK-B2 receptor mRNA
Previous studies have shown that rat glomeruli and mesangial
cells in culture express BK-binding sites [181. To determine
whether the mRNA encoding B2 receptors is expressed in mes-
angial cells, we evaluated B2 receptor mRNA expression by
RT-PCR using BK-B2 gene-specific primers. Figure 1 shows an
ethidium bromide-stained gel of the RT-PCR products following
30 cycles of PCR amplification. The results demonstrate clearly
that the B2 message is expressed in both quiescent and prolifer-
ating mesangial cells.
BK is mitogenic in mesangial cells
To evaluate the effects of BK on mesangial cell growth, we
examined the effects of BK on DNA synthesis and cell number
(Fig. 2). Cultured rat mesangial cells were made quiescent by
incubation in 0.5% FCS for 48 hours. Subsequently, the cells were
stimulated with BK alone or with BKHoe-140, a specific B2
receptor antagonist (10—6 M). Incorporation of [3Hjthymidine into
DNA did not increase at BK concentrations of 10 or 10_lu M.
Maximal responses were attained at i0 to iO M of BK. The
responses of BK were inhibited completely by the BK-B2 antag-
onist, Hoe 140, indicating that BK-induced DNA synthesis is
mediated by activation of the B7 receptor type. Hoe 140 alone had
no effect on incorporation of 3H-thymidine in mesangial cells (Fig.
2).
BK induces rapid expression of proto-oncogene c-fos mRNA
through stimulation of B2 receptors
Rapid induction of the nuclear proto-oncogenes such as c-fos
and c-jun, corresponding to specific proteins involved in gene
Fig. 2. Effect of BK on DNA 3ynthesis in mesangial cells. Quiescent
mesangial cells were stimulated with BK (10—I! to iO M) in the presence
or absence of the B2-receptor antagonist, Hoe 140 (106 M). 3H-thymidine
(1 jsCi/ml) was added 16 hours after addition of BK and the cells were
harvested at 24 hours for measurement of 3H-thymidine incorporation
into DNA (A) or cell counting (B). Baseline thymidine incorporation is
54 5 X iO cpm. Symbols are: (•) BK; () BK+Hoe 140; * < 0.05.
transcription, is recognized as a useful marker for cell growth
stimulation [19, 20]. To examine the effects of BK on induction of
c-fos and c-fun, we analyzed expression of mRNA in mesangial
cells treated with BK. Quiescent mesangial cells were stimulated
with BK (10 M) for 30 minutes and two hours and total cellular
RNA was isolated. Total RNA (20 /Lg) from BK-stimulated and
nonstimulated mesangial cells was then analyzed for c-fos and
c-jun transcripts by Northern blotting using the respective [32P]-
labeled eDNA probes. BK stimulated expression of c-fos mRNA
(Fig. 3). Increases in c-fos mRNA (up to 30-fold vs. controls)
occurred after 30 minutes of BK treatment. As expected, due to
rapid degradation of the fos message, expression of c-fos mRNAs
in response to BK was transient and not observed at two hours.
BK had no significant effect on expression of c-jun mRNA at
either 30 minutes or two hours.
Because the BK-B2 receptor type mediates the physiologic
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Fig. 3. A representative Northern blot analysis of c-fos and c-jun gene
expression in BK-stimulated rat mesangial cells. Total cellular RNA (20
pg/sample) was prepared 30 minutes and two hours after stimulation of
quiescent mesangial cells with BK (0.1 tLM) or 0.5% FCS alone (lane C).
RNA was resolved on an agarose/formaldehyde gel, transferred to a nylon
membrane and hybridized to random-primed 32P-labeled cDNA5 for c-fos,
c-fun, and GAPDH. BK caused a marked and transient induction of c-fos
mRNA expression at 30 minutes (30-fold) which was blocked by pre-
treatment of the cells with the B2-antagonist, Hoe 140 (1 M). Cultured
mesangial cells expressed basal levels of c-jun mRNA which were not
significantly affected by BK.
actions of BK, we evaluated whether this receptor is involved in
BK-induced stimulation of protooncogenes. Pre-incubation of
mesangial cells for one hour with the highly potent and selective
BK-B2 receptor antagonist, Hoe 140 (10—6 M) 1O], prior to
stimulation with BK (10 M) blunted BK-induced c-fos expression
by more than 80 11% (N = 3 experiments, P < 0.001) (Fig. 3).
BK stimulates AP-1 DNA-binding activity
The transcription factor AP-1, composed of fos/jun and jun/jun
dimers, is implicated in the sequence-specific transactivation of
growth-related genes containing TPA-responsive elements in
their promoters [191. We examined the involvement of AP-1 in the
mitogenic response of BK using gel shift assays. As shown in
Figure 4, AP-1 DNA binding activity was increased by BK (10
M). The increase in AP-1 binding activity was evident at both 30
minutes and two hours. Competition with an unlabeled AP-1
oligonucleotide containing the AP-1 consensus binding sequence
confirmed the specificity of the AP-1 complex-DNA binding
interaction. To examine the composition of the AP-1 complexes,
we carried out gel supershift experiments using c-fos antibodies.
Addition of anti-c-fos antibodies to the cell extracts 45 minutes
Fig. 4. Electrophoretic gel mobility shift assay of AP-] DNA binding activity
in BK-stimulated mesangial cells. Whole cell protein extracts (5 pg/sample)
were incubated with a 32P-labeled consensus AP-1 oligonucleotide and the
mixture was run on 6% non-denaturing polyacrylamide gel. A prominent
increase in AP-1 DNA binding activity is observed at 30 minutes following
stimulation of mesangial cells with BK (0.1 /.LM). AP-1 binding activity
remained elevated at two hours compared to controls but to a lesser extent
than at 30 minutes. Addition of 100-fold excess unlabeled AP-1 consensus
oligonucleotide to the reaction mixture abolished the band shift indicating
the specificity of protein binding to the DNA sequence.
before incubation with the labeled AP-1 consensus oligonuce-
lotide resulted in a supershift documenting that the AP-1 com-
plexes contained the fos proteins (Fig. 5). Taken together, these
data indicate that BK-stimulated c-fos expression results in in-
creased AP-1 binding activity.
Discussion
In the present study we present direct evidence that BK
effectively stimulates DNA synthesis and cell proliferation of
cultured rat mesangial cells. BK-stimulated mitogenesis in mes-
angial cells was preceded by rapid expression of the immediate
early gene, c-fos and up-regulation of AP-1 DNA binding activity,
suggesting that regulation of gene transcription by BK occurs by
AP-1-dependent mechanisms. The binding site for AP-1 is also
recognized as the TPA-response element (TRE). TPA (12-0-
tetradecanoylphorbol acetate) is a potent activator of protein
kinase C (PKC), and other agents which lead to PKC activation
such as serum and growth factors also induce expression of these
genes. The finding that BK stimulates PKC activity in mesangial
cells [18] raises the possibility that BK-induced immediate early
genes may be mediated by activation of PKC.
c-fos —ø-
c-jun -*
GAPDH —ø
-
30 mm 2 hr
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Fig. 5. Electrophoretic gel mobility shift assay of AP-1 DNA binding activity
in the presence of c-fos antibody. The assay was performed as described in
Figure 4 except that c-fos antibody was present in the incubation mixture.
BK increased AP-1 DNA binding activity at 30 minutes and two hours. In
the presence of c-fos antibody, a supershift is observed in these samples,
indicating the presence of the c-fos protein in the AP-1 complexes at both
time points.
AP-1 can exist as a fos:jun heterodimer or a jun:jun homodimer
although the latter has a considerably lower transcriptional activ-
ity than fos:jun AP-1 dimers [21, 22]. Our gel shift analysis using
fos antibodies demonstrate that in BK-stimulated cells, the AP-1
complexes formed at both 30 minutes and two hours contain c-fos
indicating the presence of fos:jun heterodimers. The transient
expression of c-fos mRNA may be explained by its rapid degra-
dation [23].
There are many examples of genes encoding proteins involved
in growth control whose expression is affected by AP-1 (TGF-a,
TGF-f3, IL-2) or whose upstream regulatory region contain AP-1
consensus elements (PDGF-BB and cyclin Dl) [19, 24—27]. The
data suggest that BK-stimulated DNA synthesis and cell prolifer-
ation may involve activation of growth factor or cell cycle control
genes by AP-1. It is worth mentioning here that the mitogenic
effect of BK is modest (up to twofold increase in DNA synthesis)
when compared to serum or mitogenic growth factors such as
PDGF which can induce more than 10-fold increase in DNA
synthesis. In this regard, BK, like other vasoactive peptides with
mitogenic activity (AVP, endothelin and angiotensin II), is a
progression factor, that is, it promotes cell cycle progression from
G1 to S. On the other hand, PDGF and other polypeptide growth
factors are competence factors and are capable of stimulating
resting cells in G0 to enter and progress through the cell cycle.
An important implication of the present findings concerns
developmental glomerular growth. Preliminary data from our
laboratory indicate that BK may also be important for glomerular
maturation. Histologic examination of fetal kidneys obtained from
rats treated in utero with salt loading and a BK-B2 receptor
blocker revealed cortical thinning and decreased number of
one of the major kinin-degrading enzymes, these findings raise the
intriguing possibility that accumulation of intrarenal BK due to
decreased degradation may have triggered these vascular changes
by stimulation of smooth muscle hyperplasia. The ability of BK to
stimulate the proliferation of cultured vascular smooth muscles
[29, 30] is in keeping with this suggestion. Furthermore, because
ACE inhibitors are used to halt the progression of chronic
glomerular diseases, it is conceivable that the accumulation of BK
may counteract the desired negative effect of angiotensin block-
ade on glomerular cell proliferation.
In summary, the present study demonstrates that BK-B2 recep-
tors expressed on mesangial cells are coupled with induction of
proto-oncogene c-fos, AP-1-DNA binding activity and DNA rep-
lication. Thus, BK-B2 receptors are a new member of G-protein-
coupled receptors which mediate ligand-induced growth re-
sponses in mesangial cells.
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